Clinical Trials Browser

OTHER_GOV × Lenalidomide × Gastrointestinal × Clear all

NCT04326296 2020-05-15

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

Phase 1 Unknown

Gastrointestinal

Colorectal Neoplasms